News | Mammography | October 01, 2015

Award-winning singer and actress will lead national campaign to increase insurance coverage for Hologic’s Genius 3D Mammography exams

X0000_Hologic_Nasdaq_opening_bell_2015.jpg

Image courtesy of Hologic


October 1, 2015 — Hologic Inc. President and CEO Steve MacMillan was joined by award-winning actress and singer Kristin Chenoweth in ringing the Nasdaq Opening Bell on October 1, the first day of Breast Cancer Awareness Month.

This is the 10th year in a row that Nasdaq has invited Hologic to preside over its Opening Bell ceremony to kick off Breast Cancer Awareness Month.

MacMillan spoke during the ceremony about Hologic’s Genius 3D Mammography technology, which clinical studies have shown is more accurate than traditional 2-D mammograms alone. The Genius exam reduces callbacks by up to 40 percent, and detect 41 percent more invasive cancers than 2-D screenings.

During Breast Cancer Awareness Month, Chenoweth will serve as spokeswoman for a national campaign to encourage insurance companies to cover Genius 3D Mammography exams. Chenoweth is the daughter of a two-time breast cancer survivor. As part of the campaign, she will conduct interviews throughout October with national and regional media outlets. In addition, a social media campaign will include the support of additional high-profile celebrities.

The Genius 3D Mammography exam is U.S. Food and Drug Administration (FDA)-approved and available on the Hologic Selenia Dimensions system. 

For more information: www.hologic.com


Related Content

News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
Subscribe Now